StockData
Natera, Inc. logo

Natera, Inc.

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30234% above fair value
$378.92−35.38 (-8.54%)

Close on Nov 2, 2026Market cap $54.62BP/E –Yield –

Natera Performance-Based Stock Award Compensation Expense by Year

Performance-Based Stock Award Compensation Expense ($M) ($M)

Natera Performance-Based Stock Award Compensation Expense: $98.8M in FY2025, up 10.0% from a year earlier.

Latest, FY2025
98.8
Period ended Dec 31, 2025
Change on a year earlier
+10.0%
89.8 in FY2024
History
7 years
Since FY2019
Sources
5
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (2026-02-27) ↗

Reported in Form 10-K/10-Q Note — Stock-Based Compensation (XBRL).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPerformance-Based Stock Award Compensation Expense ($M) ($M)Year on yearSource
FY2025Dec 31, 202598.8+10.0%Form 10-K (2026-02-27) ↗
FY2024Dec 31, 202489.8+65.7%Form 10-K (2026-02-27) ↗
FY2023Dec 31, 202354.2+12.4%Form 10-K (2026-02-27) ↗
FY2022Dec 31, 202248.2-4.2%Form 10-K (2025-02-28) ↗
FY2021Dec 31, 202150.3+192.4%Form 10-K (2023-03-01) ↗
FY2020Dec 31, 202017.2+135.6%Form 10-K (2022-02-25) ↗
FY2019Dec 31, 20197.30–Form 10-K (2021-02-26) ↗

Breakdown

What makes up performance-Based Stock Award Compensation Expense

Cite this data

StockData. (2026). Natera Performance-Based Stock Award Compensation Expense ($M), annual FY2019–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/sbc-performance-awards

See every metric in the Natera KPI table. Data updated Nov 2, 2026.